Intervention Review

Risperidone for autism spectrum disorder

  1. Ora S Jesner2,
  2. Mehrnoosh Aref-Adib2,
  3. Esther Coren3

Editorial Group: Cochrane Developmental, Psychosocial and Learning Problems Group

Published Online: 24 JAN 2007

Assessed as up-to-date: 3 APR 2006

DOI: 10.1002/14651858.CD005040.pub2

How to Cite

Jesner OS, Aref-Adib M, Coren E. Risperidone for autism spectrum disorder. Cochrane Database of Systematic Reviews 2007, Issue 1. Art. No.: CD005040. DOI: 10.1002/14651858.CD005040.pub2.

Author Information

  1. 2

    School for Policy Studies, c/o Chris Champion, ME, CDPLPG, Bristol, UK

  2. 3

    Canterbury Christ Church University, Social Work, Community and Mental Health, Canterbury, Kent, UK

*Chris Champion, School for Policy Studies, University of Bristol, 8 Priory Road, Bristol, BS8 1TZ, UK.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 24 JAN 2007


Cited in:


This article has been cited by:

  1. 1
    T.D. Vloet, B. Herpertz-Dahlmann, Therapie-Handbuch Grundwerk inkl 6. Lfg., 2015,


  2. 2
    Danielle A. Baribeau, Evdokia Anagnostou, An Update on Medication Management of Behavioral Disorders in Autism, Current Psychiatry Reports, 2014, 16, 3


  3. 3
    Tomoya Hirota, Jeremy Veenstra-VanderWeele, Eric Hollander, Taro Kishi, Antiepileptic Medications in Autism Spectrum Disorder: A Systematic Review and Meta-Analysis, Journal of Autism and Developmental Disorders, 2014, 44, 4, 948


  4. You have free access to this content4
    Katrina Williams, Susan Woolfenden, Jacqueline Roberts, Sylvia Rodger, Lawrence Bartak, Margot Prior, Autism in context 2: Assessment, intervention and services in Australia, Journal of Paediatrics and Child Health, 2014, 50, 5
  5. 5
    Amanda Sawyer, Johanna K. Lake, Yona Lunsky, Shi-Kai Liu, Pushpal Desarkar, Psychopharmacological treatment of challenging behaviours in adults with autism and intellectual disabilities: A systematic review, Research in Autism Spectrum Disorders, 2014, 8, 7, 803


  6. 6
    Nirbhay N. Singh, Giulio E. Lancioni, Bryan T. Karazsia, Alan S. W. Winton, Rachel E. Myers, Ashvind N. A. Singh, Angela D. A. Singh, Judy Singh, Mindfulness-Based Treatment of Aggression in Individuals with Mild Intellectual Disabilities: A Waiting List Control Study, Mindfulness, 2013, 4, 2, 158


  7. 7
    Christine M. Freitag, Autistische Störungen – State-of-the-Art und neuere Entwicklungen, Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie, 2012, 40, 3, 139


  8. 8
    Gerd Lehmkuhl, Judith Sinzig, Tanja Sappok, Albert Diefenbacher, Psychische Erkrankungen, 2012,


  9. 9
    Dieter Ebert, Ludger Tebartz van Elst, Psychische Erkrankungen, 2012,


  10. 10
    Katrina Williams, Danielle M Wheeler, Natalie Silove, Philip Hazell, Cochrane Review: Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD), Evidence-Based Child Health: A Cochrane Review Journal, 2011, 6, 4
  11. 11
    Gemma L. Unwin, Shoumitro Deb, Efficacy of atypical antipsychotic medication in the management of behaviour problems in children with intellectual disabilities and borderline intelligence: A systematic review, Research in Developmental Disabilities, 2011, 32, 6, 2121


  12. 12
    Despina G. Contopoulos-Ioannidis, Maria S. Baltogianni, John P.A. Ioannidis, Comparative Effectiveness of Medical Interventions in Adults Versus Children, The Journal of Pediatrics, 2010, 157, 2, 322


  13. 13
    Thilinie Rajapakse, Tamara Pringsheim, Pharmacotherapeutics of Tourette Syndrome and Stereotypies in Autism, Seminars in Pediatric Neurology, 2010, 17, 4, 254


  14. 14
    Isabelle Rapin, Roberto F. Tuchman, Autism: Definition, Neurobiology, Screening, Diagnosis, Pediatric Clinics of North America, 2008, 55, 5, 1129


  15. 15
    Peter Sturmey, Laura Seiverling, John Ward-Horner, Clinical Assessment and Intervention for Autism Spectrum Disorders, 2008,


  16. 16
    Vikram Patel, Ricardo Araya, Sudipto Chatterjee, Dan Chisholm, Alex Cohen, Mary De Silva, Clemens Hosman, Hugh McGuire, Graciela Rojas, Mark van Ommeren, Treatment and prevention of mental disorders in low-income and middle-income countries, The Lancet, 2007, 370, 9591, 991


  17. 17
    Heidi Ching, Tamara Pringsheim, Aripiprazole for autism spectrum disorders (ASD), The Cochrane Library,
  18. 18
    Ann Couteur, Peter Szatmari, Autism spectrum disorder,
  19. 19
    Tao Xiong, Hongju Chen, Rong Luo, Dezhi Mu, Hyperbaric oxygen therapy for autism spectrum disorder (ASD) in children and adults, The Cochrane Library,
  20. 20
    Toni Redman, Elly Scheermeyer, Makoto Ogawa, Eddie C Sparks, Jeremy C Taylor, Vi T Tran, Nancy Sturman, Mieke L van Driel, Methylphenidate for core and ADHD-like symptoms in children aged 6 to 18 years with autism spectrum disorders (ASDs), The Cochrane Library,
  21. 21
    Nuala Livingstone, Geraldine Macdonald, Katrina Williams, Deborah M Caldwell, Louise Brigid Baker, Philip Hazell, Pharmacological intervention for irritability, aggression, and self-injury in Autism Spectrum Disorders (ASD), The Cochrane Library,
  22. 22
    Heidre Bezuidenhout, Charles Shey Wiysonge, Judith M Bentley, Risperidone for disruptive behaviour disorders in children with intellectual disabilities, The Cochrane Library,
  23. 23
    Katrina Williams, Amanda Brignell, Melinda Randall, Natalie Silove, Philip Hazell, Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD), The Cochrane Library,
  24. 24
    Katrina Williams, Danielle M Wheeler, Natalie Silove, Philip Hazell, Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD), The Cochrane Library,